Divalproex sodium and Infusion site extravasation - a phase IV clinical study of FDA data

Summary:

Infusion site extravasation is reported as a side effect among people who take Divalproex sodium (divalproex sodium), especially for people who are female, 40-49 old, also take Gabapentin, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Infusion site extravasation when taking Divalproex sodium. It is created by eHealthMe based on reports of 9,295 people who have side effects when taking Divalproex sodium from the FDA, and is updated regularly.

What is Divalproex sodium?

Divalproex sodium has active ingredients of divalproex sodium. It is often used in epilepsy. eHealthMe is studying from 9,483 Divalproex sodium users. Check the latest studies of Divalproex sodium.

What is Infusion site extravasation?

Infusion site extravasation (flow of (blood or lymph) from infusion site) is found to be associated with 650 drugs and 590 conditions by eHealthMe. Check the latest studies of Infusion site extravasation.

On Aug, 12, 2026

9,295 people reported to have side effects when taking Divalproex sodium.
Among them, 15 people (0.16%) have Infusion site extravasation.

Could Divalproex sodium cause Infusion site extravasation?

Among these 15 people:

What is the gender of people who have Infusion site extravasation when taking Divalproex sodium? *

female: 100 %
male: 0.0 %

What is the age of people who have Infusion site extravasation when taking Divalproex sodium? *

What are other drugs people take besides Divalproex sodium? *

What are other side effects people have besides Infusion site extravasation? *

Cellulitis (infection under the skin): 10 people, 66.67%
Rashes (redness): 10 people, 66.67%
Eye Swelling: 7 people, 46.67%
Ill-Defined Disorder: 7 people, 46.67%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 7 people, 46.67%
Generalised Oedema (swelling all over the body): 7 people, 46.67%
Injection Site Pain: 7 people, 46.67%
Dyschezia (difficulty in defecating): 7 people, 46.67%
Staphylococcal Infection (an infection with staphylococcus bacteria): 7 people, 46.67%
Injection Site Swelling: 7 people, 46.67%

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 7 people, 46.67%
Immunodeficiency Common Variable: 7 people, 46.67%
Stiff Person Syndrome: 1 person, 6.67%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Divalproex sodium and have Infusion site extravasation?

- Check whether Infusion site extravasation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Divalproex sodium:

Divalproex sodium (9,483 reports)

Browse all side effects of Divalproex sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infusion site extravasation:

Infusion site extravasation (650 drugs)

Browse all the conditions that are associated with Infusion site extravasation:

Infusion site extravasation (590 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on divalproex sodium (the active ingredients of Divalproex sodium) and Divalproex sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.